Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress

25 11 月, 2025

One Min Read

7 Views

原文: https://finance.yahoo.com/news/intellia-therapeutics-ntla-downgraded-safety-133913607.html

Last Update: 25 11 月, 2025

Written By

Other Articles

Previous

William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty

Next

<div>Bitcoin Gets Kicked Out of the $2 Trillion Club. Here’s Why This Top Bitcoin ETF Is a Buy Anyway.</div>

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept